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ADDENDUM
STUDIES ON A POSSIBLE MICROBIAL AETIOLOGY FOR THE DIFFERENCES IN
MALIGNANCY BETWEEN THE WBPI SUBLINES
A. E. WILLIAMS AND N. A. RATCLIFFE
From the Department ofMicrobiology, The University, Birmingham 15
THE malignancies ofthe sublines ofthe WBP1 rat tumour are related to their
abilities to induce a fatal hypoglycaemia (see above). The more malignant sub-
lines, V and X, arose during serial ascites passage ofthe A subline, presumablyby
selection of more malignant cells from the total population. However, the appa-
rent increase in malignancy could have been due to the acquisition of an infectious
agent, during animal passage, which contributed to thepathological effects, either
independently or in conjunction with the tumour cells. The association of such
agents with transplantable tumours and their contribution to the overall disease
syndrome have been reported (Belcher and Simpson, 1960; Davies, Cross and
Lapis, 1962; Stansly, 1965). It appeared unlikely that such an association had
occurred in the WBPI system as the tumours had been passaged for a relatively
shortperiod and thepathogenesis ofthethree sublines wassimilar, although occur-
ring at different rates. Nevertheless, evidence to support this view was desirable,
because the relevance of the studies on hypoglyeaemia to the biology of cancer
depended on there being a genuine difference in malignancy between the sublines.
Such evidence wouldnecessarily benegative, i.e. the absence of an infectious agent would be indicated by the failure ofexperiments designed to detect its presence.
Despite this limitation, four investigations to demonstrate the pre.sence of a
pathogenic butnon-oncogenic agent in the V tumour were undertakenby methods
that have beensuccessfullyusedpreviously(Stansly, 1965). No evidence that any infectious agent was responsible for the differences in malignancy was obtained.
First, normal rats and mice were examined forpathological effectsfollowing the
injection of extracts of V cells or of serum from rats bearing the V tumour (cf.
Davies etal., 1962), so that anychanges could be compared with thoseproducedby activetumourgrowth(Williamsetal.,1968;Killingtonetal.,1971). Vcellsuspen- sions, disruptedbyultrasonication, homogenization (two methods) orfreezing and
thawing, werecentrifuged (26,000 x g 30 min., 4' C.) and thesupernatants filtered
(0-22 #pore membrane filter). These extracts were termed V15. Some V15
extracts were further centrifuged (150,000 x g, 90 min., 4' C.); the supernatant (V45s) and thepelletsresuspended inTyrode solution (V45p) were then filtered (as104 KILLINGTON, WILLIAMS, RATCLIFFE, WHITEHEAD AND SMITH
above). In several experiments (involving > 150 animals), in which animals
receivedi.p. injections ofthe above cell free V extracts (=-= I X 108 cells) or serum
(0-8 ml.) from rats bearing V tumour, no deaths occurred nor were any patho-
logical changes detectable by periodic (every 2 days for 21 days post injection)
measurements ofhaematocrit, haemoglobin, red cell count and spleen weight and
assays for the 14 biochemical constituents of sera analysed by Killington et al.
(1971) during growth of the WBP1 tumours. No changes significantly different
from normal values were observed in any of these parameters.
Second, attempts were made to decrease the mean death times (MDT)produced
by the A tumour (Smith et al., 1968) by injecting it (I x 101 cells i.p.) into rats,
together with cell-free extracts ofV cells (V15, V45s andV45p extracts
== I X 108
V cells, prepared as above). Any infectious agent in the extracts might thus
produce an increased pathological effect in association with the A tumour (cf. the
changes in tumourpathogenesis inducedby variousnon-oncogenic viruses; Nelson
1959; Stewart and Haas, 1956; Riley, 1961). In a number ofexperiments with
many (500) animals MDT was determined at the first passage ofA cells after treat-
ment with V cell extracts and onsubsequent passage in anattempt todistinguish a
permanent increase in malignancy, due possibly to an infectious agent, from a
temporary effect of the V cell extract on the A cells (cf. the temporary virulence
enhancing effects of cell components of virulent bacterial strains on avirulent
strains). The results werecomplicatedbythe naturalprogression ofthe untreated
A cell populations, which during repeated passage in several experiments showed
random decreases in NMT. For example, although all samples of untreated A
cells produced MDT ofapproximately 33 days at the first passage, by the fourth
passage MDT of 19-4, 24-0, 33.0, 15-6, 23-2, 24-6 and 18-2 days were recorded on
different occasions. Decreases in MDT also occurred during serial passage of A
cells treated with cell-free extracts of V cells during the first passage. However,
these decreases were again random in occurrence and extent and in no way correlated with the initial treatment ofthe A cells.
Third, ifthe increasedmalignancy ofthe V subline were due to infection ofthe
cells with Eperythrozoon coccoides (Stansly, 1965) or a mycoplasma, treatment of
rats with oxytetracycline (an antibiotic to which these organisms are usually sensitive), might have caused an increase in the MDTproducedby V cells. Thus,
the MDT produced by V cells (1 X 107 i.p.) was compared in rats receiving
oxytetracycline(I5 mg. i.m.dailyfor 8days) andinuntreatedrats. Nodifferences
in MDT between the groups was observed.
Fourth, A and V tumours were examined by electron microscopy for the
presence ofmycoplasma or virus, although detection ofparticles would not neces-
sarily have indicated a relevant agent in the absence of biological activity. Specimens included intact tumour cells, and pellets obtained by high speed centrifugation (150,000 x g; 90 min.) of disrupted suspensions of A and V cells
and of sera from normal and A and V tumour-bearing rats. No intracellular or
extracellular structures resembling infectious agents were seen in any of the
samples.
Lack of evidence for a phenomenon can never disprove its existence. Never-
theless, untilevidence tothecontraryispresented, thesefourinvestigationssupport the conclusionthatthe difference inmalignancybetween WBPI (A) andWBPI (V) sublines is a genuine property ofthe cells and is not mediatedby anon-oncogenic infectious agent associated with the V cells alone.HYPOGLYCAEMIA AND MALIGNANCY DIFFERENCES 105
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